Nonalcoholic Fatty Liver Disease Program

The Division of Liver Diseases at Mount Sinai specializes in the care of nonalcoholic fatty liver disease, a chronic liver disease that can range from a mild condition to an inflammatory, life-threatening illness that can lead to cirrhosis and/or liver cancer. The disease is often associated with metabolic syndrome which is characterized by obesity, diabetes, hypercholesterolemia and high blood pressure. These components of metabolic syndrome are becoming more common in adults and children, which has led to increasing recognition of patients with non-alcoholic fatty liver disease.

Multidisciplinary Care for Liver Disease

At Mount Sinai, our liver disease experts offer treatment strategies that target these underlying risk factors. In collaboration with the Diabetes Center and our weight loss and bariatric surgery teams, we offer a multidisciplinary approach to managing the disease. We also provide referrals to the Recanati/Miller Transplantation Institute for liver transplantation if needed for patients with end-stage liver disease. Patients with liver cancer due to fatty liver disease are managed in conjunction with the transplant team, interventional radiology and surgical oncology.

Our patients also have access to clinical trials at Mount Sinai, which offer promising new experimental treatments for nonalcoholic fatty liver disease.